These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 19250160)

  • 1. Decrease of reported adverse events to injectable polylactic acid after recommending an increased dilution: 8-year results from the Injectable Filler Safety study.
    Rossner F; Rossner M; Hartmann V; Erdmann R; Wiest LG; Rzany B
    J Cosmet Dermatol; 2009 Mar; 8(1):14-8. PubMed ID: 19250160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk profiles of different injectable fillers: results from the Injectable Filler Safety Study (IFS Study).
    Zielke H; Wölber L; Wiest L; Rzany B
    Dermatol Surg; 2008 Mar; 34(3):326-35; discussion 335. PubMed ID: 18177399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The spectrum of adverse reactions after treatment with injectable fillers in the glabellar region: results from the Injectable Filler Safety Study.
    Bachmann F; Erdmann R; Hartmann V; Wiest L; Rzany B
    Dermatol Surg; 2009 Oct; 35 Suppl 2():1629-34. PubMed ID: 19807757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse reactions caused by consecutive injections of different fillers in the same facial region: risk assessment based on the results from the Injectable Filler Safety study.
    Bachmann F; Erdmann R; Hartmann V; Becker-Wegerich P; Wiest L; Rzany B
    J Eur Acad Dermatol Venereol; 2011 Aug; 25(8):902-12. PubMed ID: 21054567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse reactions to injectable soft tissue fillers.
    Requena L; Requena C; Christensen L; Zimmermann US; Kutzner H; Cerroni L
    J Am Acad Dermatol; 2011 Jan; 64(1):1-34; quiz 35-6. PubMed ID: 21167403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse reactions to injectable soft tissue permanent fillers.
    Christensen L; Breiting V; Janssen M; Vuust J; Hogdall E
    Aesthetic Plast Surg; 2005; 29(1):34-48. PubMed ID: 15759096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NewFill for skin augmentation: a new filler or failure?
    Beljaards RC; de Roos KP; Bruins FG
    Dermatol Surg; 2005 Jul; 31(7 Pt 1):772-6; discussion 776. PubMed ID: 16029705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgery for foreign body reactions due to injectable fillers.
    Wolfram D; Tzankov A; Piza-Katzer H
    Dermatology; 2006; 213(4):300-4. PubMed ID: 17135735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complications associated with injectable soft-tissue fillers: a 5-year retrospective review.
    Daines SM; Williams EF
    JAMA Facial Plast Surg; 2013 May; 15(3):226-31. PubMed ID: 23539246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early granulomatous foreign body reactions to a novel alginate dermal filler: the system's failure?
    Schuller-Petrović S; Pavlović MD; Schuller SS; Schuller-Lukić B; Neuhold N
    J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):121-3. PubMed ID: 21929551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the poly-L-lactic acid implant for treatment of the nasolabial fold: 3-year follow-up evaluation.
    Salles AG; Lotierzo PH; Gimenez R; Camargo CP; Ferreira MC
    Aesthetic Plast Surg; 2008 Sep; 32(5):753-6. PubMed ID: 18551341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soft-tissue augmentation and the role of poly-L-lactic acid.
    Vleggaar D
    Plast Reconstr Surg; 2006 Sep; 118(3 Suppl):46S-54S. PubMed ID: 16936544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of injection with poly-L-lactic acid compared with hyaluronic acid for correction of nasolabial fold: a randomized, evaluator-blinded, comparative study.
    Hyun MY; Lee Y; No YA; Yoo KH; Kim MN; Hong CK; Chang SE; Won CH; Kim BJ
    Clin Exp Dermatol; 2015 Mar; 40(2):129-35. PubMed ID: 25319932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NewFill for skin augmentation: a new filler or failure?
    Burgess CM; Lowe NJ
    Dermatol Surg; 2006 Dec; 32(12):1530-2; author reply 1532. PubMed ID: 17199668
    [No Abstract]   [Full Text] [Related]  

  • 15. Risk of severe adverse reactions to an injectable filler based on a fixed combination of hydroxyethylmethacrylate and ethylmethacrylate with hyaluronic acid.
    Rossner M; Rossner F; Bachmann F; Wiest L; Rzany B
    Dermatol Surg; 2009 Feb; 35 Suppl 1():367-74. PubMed ID: 19207327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of adverse reactions to injectable filler substances on quality of life: results from the Berlin Injectable Filler Safety (IFS) - study.
    Düker D; Erdmann R; Hartmann V; Nast A; Rzany B; Bachmann F
    J Eur Acad Dermatol Venereol; 2016 Jun; 30(6):1013-20. PubMed ID: 26916470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minimizing adverse events associated with poly-L-lactic acid injection.
    Narins RS
    Dermatol Surg; 2008 Jun; 34 Suppl 1():S100-4. PubMed ID: 18547172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Collagen Stimulators: Poly-L-Lactic Acid and Calcium Hydroxyl Apatite.
    Breithaupt A; Fitzgerald R
    Facial Plast Surg Clin North Am; 2015 Nov; 23(4):459-69. PubMed ID: 26505542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Injectable poly-L-lactic acid (Sculptra): technical considerations in soft-tissue contouring.
    Lam SM; Azizzadeh B; Graivier M
    Plast Reconstr Surg; 2006 Sep; 118(3 Suppl):55S-63S. PubMed ID: 16936545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse reactions to polylactic acid injections in the periorbital area.
    Apikian M; Roberts S; Goodman GJ
    J Cosmet Dermatol; 2007 Jun; 6(2):95-101. PubMed ID: 17524125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.